Peptide mapping

What is a peptide map?

A peptide map is a chromatogram of the pieces a molecule breaks into when a specific enzyme or chemical cuts it at known points. ICH Q6B describes it as selective fragmentation of the product into discrete peptides using suitable enzymes or chemicals, with the fragments analysed by HPLC or another appropriate procedure and identified, to the extent possible, by techniques such as amino acid analysis, N-terminal sequencing or mass spectrometry (ICH Q6B).

Because the enzyme cuts at predictable residues, the expected fragments can be listed from the sequence in advance. The test is whether the fragments that appear match that list.

How is a peptide map made in the laboratory?

1. Prepare the sample. For proteins, disulfide bonds are typically reduced and the cysteines alkylated so the bonds cannot re-form and the enzyme can reach its cut sites (Hoofnagle and colleagues, Clinical Chemistry, 2016).
2. Digest. An enzyme cuts the chain. A 2023 review in mAbs on mass-spectrometry-based quality control names trypsin as the standard enzyme, with Lys-C, Glu-C or Asp-N used where trypsin does not give enough coverage (Yang and colleagues, mAbs, 2023).
3. Separate. The fragments are run on reversed-phase liquid chromatography, the same kind used for HPLC-UV.
4. Identify. Each peak's mass is measured by mass spectrometry and, ideally, the fragment is broken again (MS/MS) to read its sequence.
5. Compare. The observed fragments are matched to the expected list and, where available, to a reference standard digested side by side.

Why map when you can just measure the intact mass?

An intact mass from LC-MS or HRMS says the whole molecule weighs the right amount. It cannot say where a difference sits, and two residues swapped in position give exactly the same total. A map breaks the question into smaller ones: each fragment covers a stretch of the sequence, so a wrong residue shows up as one fragment with an unexpected mass while the others still match.

ICH Q6B notes that peptide mapping with a validated procedure is frequently used to confirm product structure for lot release, and that mapping under reducing and non-reducing conditions, with mass spectrometry, can locate free sulfhydryl groups and disulfide bridges.

Is peptide mapping useful for short synthetic peptides?

Mostly for longer ones. The European Medicines Agency's draft guideline on synthetic peptides says peptide mapping may be applicable for longer peptides, and its example characterisation table lists LC-MS/MS of the intact molecule for sequence confirmation, with LC-MS of enzymatically digested material (peptide mapping) for long peptides (EMA draft guideline on synthetic peptides, 2023). It also lists peptide mapping among the acceptable identification methods for release.

What does sequence coverage mean?

Sequence coverage is the share of the residues in the expected sequence that fall inside at least one identified fragment. Full coverage means every residue was seen in some fragment. Yang and colleagues note that some molecules need more than one enzyme, with trypsin combined with Glu-C or Asp-N, to reach full sequence coverage. A map with partial coverage confirms only the regions it covers.

Can the digestion step itself create changes?

Yes. Yang and colleagues report that the alkaline pH and raised temperature used to speed up trypsin can introduce artificial asparagine deamidation and N-terminal glutamine cyclisation, and that stopping the digestion with formic acid can introduce oxidation artefacts. An unexpected modification on a map is a finding to confirm against a reference standard digested in the same run before it is attributed to the vial.

Does Tested.ph offer peptide mapping?

No, and it is not planned. Most compounds people ask about are short to mid-length synthetic peptides, where intact mass by LC-MS is the practical identity check; that is what the standard package uses, performed by the partner laboratory when testing opens. The lesson on identity covers what an intact mass can and cannot rule out.